News | 12 June 2012
MUMBAI: Surya Pharmaceutical, a Rs 1650-crore mid-sized company, has become a victim of promoters' indebtedness. On Monday, the stock slipped to its lowest since listing, with brokers attributing the fall to a sustained selling pressure due to the ...
Click on the link to read the full article at Economic Times
(This link will open in a new window)